Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Cobbs Allen Capital Holdings Reports $478.6M Loss

Cobbs Allen Capital Holdings widened its net loss to $478.6 million in 2025 from $108.7 million in 2024, as operating costs more than doubled and other expenses increased sharply.

Revenue rose 6.1% to $299.2 million from $282.0 million, but operating expenses climbed to $735.4 million from $370.9 million. The biggest driver was commissions, salaries and benefits, which jumped to $670.3 million from $320.5 million. Other operating expense, net, also increased to $57.6 million from $42.8 million, while depreciation edged up to $1.3 million from $0.8 million and amortization slipped to $6.2 million from $6.9 million.

That pushed operating loss to $436.2 million, compared with $88.9 million a year earlier. Below operating income, other expenses widened to $50.8 million from $15.8 million, including $40.5 million of other expense, net versus $4.2 million in 2024. Interest expense rose to $10.3 million from $9.0 million.

The company reported an income tax benefit of $8.4 million in 2025, versus tax expense of $4.0 million in 2024.

On the balance sheet, total assets fell to $373.6 million from $422.5 million. Cash and cash equivalents dropped to $13.7 million from $43.4 million, fiduciary cash declined to $88.8 million from $119.9 million, and total current assets fell to $275.9 million from $318.5 million. Property and equipment rose to $10.8 million from $8.1 million, while intangible assets declined to $23.9 million from $28.4 million.

Total liabilities increased to $1.436 billion from $1.059 billion. Current liabilities surged to $1.416 billion from $299.6 million, driven by current portion of long-term debt rising to $137.2 million from $19.0 million and current portion of accrued stock-based compensation jumping to $983.2 million from zero. At the same time, long-term debt fell to zero from $124.6 million, and accrued stock-based compensation dropped to zero from $613.8 million.

Redeemable members’ interests deepened to a deficit of $1.062 billion from a deficit of $649.6 million. Noncontrolling interests moved to a deficit of $0.2 million from a positive $2.8 million. Total liabilities, redeemable interests and noncontrolling interests remained equal to total assets at $373.6 million.

Cash used in operations increased to $46.2 million from $35.9 million. Stock-based compensation expense rose to $423.1 million from $129.2 million, while redemptions of liability-classified membership units eased to $21.8 million from $45.7 million.

Investing activity used $0.8 million in 2025, versus $3.6 million of cash provided in 2024. The company recorded $3.5 million of property and equipment purchases, $1.7 million of intangible asset purchases, and $8.4 million of repayments from subordinated notes, partly offset by $4.0 million of proceeds from sale of equity method investments.

Financing activity used $14.0 million in 2025, reversing a $70.0 million inflow in 2024. Member contributions increased to $30.6 million from $2.8 million, but long-term debt repayments rose to $47.9 million from $13.6 million. Proceeds from long-term debt fell to $36.1 million from $42.0 million, and fiduciary cash decreased by $31.1 million after increasing by $41.6 million a year earlier.

At year-end, cash and cash equivalents plus fiduciary cash totaled $102.5 million, down from $163.6 million. Following these announcements, the company's shares moved 0.13%, and are now trading at a price of $31.85. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS